New catheter aims to better predict heart surgery outcomes
NCT ID NCT07500025
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a special catheter that measures how well the right side of the heart is working in 8 people with severe tricuspid regurgitation (a leaky heart valve). Participants are already scheduled for a procedure to fix the valve. The goal is to see if this tool can help doctors better understand patient risk before treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION (TR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New artificial heart valve could help patients too sick for surgery
- Heart failure drug vericiguat faces new test in tricuspid regurgitation patients
- Heart rhythm disorder may reshape valve before leaks start
- Can early rhythm control save hearts in AF patients with leaky valves?
- New clip device tested for leaky heart valve fix
- Heart valve repair may unlock higher doses of key heart failure drugs